Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones

[1]  Xuejun Jiang,et al.  H3K4me3 regulates RNA polymerase II promoter-proximal pause-release , 2023, Nature.

[2]  J. Tobias,et al.  Ferroptosis of tumour neutrophils causes immune suppression in cancer , 2022, Nature.

[3]  B. Stockwell.  Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications , 2022, Cell.

[4]  T. Vanden Berghe,et al.  Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity , 2022, Nature Communications.

[5]  E. Leung,et al.  In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy , 2022, Exploration of targeted anti-tumor therapy.

[6]  Xuejun Jiang,et al.  Ferroptosis at the intersection of lipid metabolism and cellular signaling. , 2022, Molecular cell.

[7]  V. O’Donnell.  New appreciation for an old pathway: the Lands Cycle moves into new arenas in health and disease , 2022, Biochemical Society transactions.

[8]  W. Zou,et al.  CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. , 2022, Cancer cell.

[9]  OUP accepted manuscript , 2022, Nucleic Acids Research.

[10]  H. Shindou,et al.  Update and nomenclature proposal for mammalian lysophospholipid acyltransferases, which create membrane phospholipid diversity , 2021, The Journal of biological chemistry.

[11]  J. Dittmer.  Nuclear Mechanisms Involved in Endocrine Resistance , 2021, Frontiers in Oncology.

[12]  B. Stockwell,et al.  iPLA2β-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4 , 2021, Nature Communications.

[13]  Kellen L. Olszewski,et al.  DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer , 2021, Nature.

[14]  W. Figg,et al.  Resistance to second-generation androgen receptor antagonists in prostate cancer , 2021, Nature Reviews Urology.

[15]  Maojie Yang,et al.  CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. , 2021, Cell metabolism.

[16]  B. Stockwell,et al.  Ferroptosis: mechanisms, biology and role in disease , 2021, Nature Reviews Molecular Cell Biology.

[17]  I. Bahar,et al.  Phospholipase iPLA2β Averts Ferroptosis By Eliminating A Redox Lipid Death Signal , 2020, Nature Chemical Biology.

[18]  C. Rudin,et al.  Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer , 2020, Cell reports.

[19]  C. Thompson,et al.  Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis , 2020, Proceedings of the National Academy of Sciences.

[20]  Callen T. Wallace,et al.  PLA2G6 guards placental trophoblasts against ferroptotic injury , 2020, Proceedings of the National Academy of Sciences.

[21]  Konnor C. La,et al.  Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers , 2020, Nature Chemical Biology.

[22]  Vianne R. Gao,et al.  Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer , 2020, Cancer cell.

[23]  D. Pe’er,et al.  Regenerative potential of prostate luminal cells revealed by single-cell analysis , 2020, Science.

[24]  Stephen A. Sastra,et al.  Cysteine depletion induces pancreatic tumor ferroptosis in mice , 2020, Science.

[25]  C. Arteaga,et al.  Overcoming Endocrine Resistance in Breast Cancer. , 2020, Cancer cell.

[26]  I. Bahar,et al.  Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death , 2020, Nature Chemical Biology.

[27]  B. Stockwell,et al.  GTP Cyclohydrolase 1/Tetrahydrobiopterin Counteract Ferroptosis through Lipid Remodeling , 2019, ACS central science.

[28]  Edward W. Tate,et al.  FSP1 is a glutathione-independent ferroptosis suppressor , 2019, Nature.

[29]  J. Olzmann,et al.  The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit ferroptosis , 2019, Nature.

[30]  B. Stockwell,et al.  Intercellular interaction dictates cancer cell ferroptosis via Merlin-YAP signalling , 2019, Nature.

[31]  P. Dobrzyn,et al.  Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer , 2019, Cancers.

[32]  D. Green.  The Coming Decade of Cell Death Research: Five Riddles , 2019, Cell.

[33]  B. Stockwell,et al.  Imidazole Ketone Erastin Induces Ferroptosis and Slows Tumor Growth in a Mouse Lymphoma Model. , 2019, Cell chemical biology.

[34]  Shibing Deng,et al.  Cystine–glutamate antiporter xCT deficiency suppresses tumor growth while preserving antitumor immunity , 2019, Proceedings of the National Academy of Sciences.

[35]  A. Chinnaiyan,et al.  CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy , 2019, Nature.

[36]  J. Olzmann,et al.  Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State. , 2019, Cell chemical biology.

[37]  Asher Mullard.  First targeted protein degrader hits the clinic , 2019, Nature Reviews Drug Discovery.

[38]  Minghui Gao,et al.  Role of Mitochondria in Ferroptosis. , 2019, Molecular cell.

[39]  F. Torti,et al.  Steroyl-CoA Desaturase 1 (SCD1) protects ovarian cancer cells from ferroptotic cell death. , 2019, Cancer research.

[40]  Kendall R. Sanson,et al.  Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities , 2018, Nature Communications.

[41]  Jason S. Lewis,et al.  A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer , 2018, Clinical Cancer Research.

[42]  Wei Li,et al.  BAP1 links metabolic regulation of ferroptosis to tumor suppression , 2018, Nature Cell Biology.

[43]  David S. Wishart,et al.  MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis , 2018, Nucleic Acids Res..

[44]  Henry W. Long,et al.  Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer , 2017, eLife.

[45]  A. Walch,et al.  ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. , 2017, Nature chemical biology.

[46]  Simon C Watkins,et al.  Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. , 2017, Nature chemical biology.

[47]  I. Goldstein,et al.  Steroid Receptors Reprogram FoxA1 Occupancy through Dynamic Chromatin Transitions , 2016, Cell.

[48]  V. Arora,et al.  Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer , 2015, Nature Reviews Cancer.

[49]  G. Superti-Furga,et al.  Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death , 2015, ACS chemical biology.

[50]  W. Gu,et al.  Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.

[51]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[52]  Alexandro E. Trevino,et al.  Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex , 2014, Nature.

[53]  Jun S. Liu,et al.  MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens , 2014, Genome Biology.

[54]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[55]  E. Cuppen,et al.  Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures , 2014, Cell.

[56]  Jindan Yu,et al.  Cooperativity and Equilibrium with FOXA1 Define the Androgen Receptor Transcriptional Program , 2014, Nature Communications.

[57]  Matthew E. Welsch,et al.  Regulation of Ferroptotic Cancer Cell Death by GPX4 , 2014, Cell.

[58]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[59]  Christof Fellmann,et al.  An optimized microRNA backbone for effective single-copy RNAi. , 2013, Cell reports.

[60]  D. Zheng,et al.  Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade , 2013, Cell.

[61]  D. Zheng,et al.  ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss , 2013, Nature Medicine.

[62]  J. Balsinde,et al.  Phospholipid sources for adrenic acid mobilization in RAW 264.7 macrophages. Comparison with arachidonic acid. , 2012, Biochimica et biophysica acta.

[63]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[64]  H. Scher,et al.  Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer , 2009, Science.

[65]  R. Murphy,et al.  Lysophospholipid Acyltransferases and Arachidonate Recycling in Human Neutrophils* , 2008, Journal of Biological Chemistry.

[66]  Takao Shimizu,et al.  Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity , 2008, Proceedings of the National Academy of Sciences.

[67]  M. Gelb,et al.  Cloning and recombinant expression of human group IIF-secreted phospholipase A(2). , 2000, Biochemical and biophysical research communications.

[68]  R. Branch,et al.  Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth. , 1999, Circulation research.